Keyphrases
Methylenetetrahydrofolate Reductase (MTHFR)
100%
Methotrexate
100%
Adverse Effects
100%
Rheumatoid Arthritis
100%
A1298C Polymorphism
100%
Genotype
50%
Plasma Homocysteine
37%
Disease Activity
37%
C677T Polymorphism
25%
Healthy Controls
12%
Polymorphism
12%
Low Dose Rate
12%
Clinical Interview
12%
Adverse Reactions
12%
Odds Ratio
12%
Confidence Interval
12%
Univariate Analysis
12%
Activity Variable
12%
Genotype Distribution
12%
Allele Distribution
12%
Genotype Analysis
12%
Serum Folate
12%
Rheumatoid Patients
12%
Methotrexate Toxicity
12%
Toxicity Activity
12%
Folate Concentrations
12%
Nursing and Health Professions
Rheumatoid Arthritis
100%
Methotrexate
100%
5,10 Methylenetetrahydrofolate Reductase (FADH2)
100%
Inflammatory Arthritis
100%
Disease Activity
33%
Homocysteine
33%
Side Effect
22%
Cross-Sectional Study
11%
Confidence Interval
11%
Adverse Event
11%
Physical Examination
11%
Odds Ratio
11%
Univariate Analysis
11%
Folic Acid Blood Level
11%
Wild Type
11%
Pharmacology, Toxicology and Pharmaceutical Science
Methotrexate
100%
Rheumatoid Arthritis
100%
5,10 Methylenetetrahydrofolate Reductase (FADH2)
100%
Inflammatory Arthritis
100%
Homocysteine
33%
Disease Activity
33%
Side Effect
22%
Adverse Event
11%
Folic Acid
11%
Cross-Sectional Study
11%